dc.contributor.author |
Bujor, Oxana |
|
dc.date.accessioned |
2020-09-15T08:54:19Z |
|
dc.date.available |
2020-09-15T08:54:19Z |
|
dc.date.issued |
2017 |
|
dc.identifier.citation |
BUJOR, Oxana. Eficacitatea comparativă a tratamentului biologic cu Tocilizumab la bolnavii cu artrită reumatoidă. In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 76-78. ISSN 1729-8687. |
|
dc.identifier.issn |
1729-8687 |
|
dc.identifier.uri |
http://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/11590 |
|
dc.description |
Departamentul Medicină Internă,
USMF Nicolae Testemițanu,
IMSP Spitalul Clinic Republican |
en_US |
dc.description.abstract |
Rheumatoid arthritis is a severe, chronic, infl ammatory
disorder, that typically affect small joints, with subsequently
loss of function of the affected joints and lead to disability.Rheumatoid arthritis has a possible systemic involvement,
which leads to reduction of life-expectancy, which in some
studies amounts 5-10 years. The key point of our study is
that tocilizumab is an effective treatment of rheumatoid
arthritis, the majority of patients treated with tocilizumab
had an obvious improvement in remission criteria. |
en_US |
dc.language.iso |
ro |
en_US |
dc.publisher |
Asociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldova |
en_US |
dc.relation.ispartof |
Sănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova |
|
dc.subject.ddc |
616.72-002.77-085.37 |
en_US |
dc.title |
Eficacitatea comparativă a tratamentului biologic cu Tocilizumab la bolnavii cu artrită reumatoidă |
en_US |
dc.title.alternative |
Comparative efficacy of biological treatment with Tocilizumab in patients with rheumatoid arthritis |
en_US |
dc.type |
Other |
en_US |